NAD says hair supplement claims stretch accuracy
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Division advises Irish firm Lifes2Good Natural Healthcare to modify advertising for its Viviscal dietary supplement - promoted to nourish hair follicles with vitamin C, silica and glycosaminoglycans - to assure it is gender neutral. The marketing in question comprised radio, print and Internet ads, including one that featured the testimonial of an actress and "health enthusiast" as well as the statement that one in three women will be affected by thinning hair during their lifetime, according to the division of the Council of Better Business Bureaus. NAD determined that because the studies supporting the efficacy of the product were conducted on men only, the advertiser should revise its ads to avoid indicating the product has been shown to work in women. NAD also recommended the firm discontinue the claim the product is "doctor recommended." Lifes2Good substantiated the claim the product is "Recommended by top celebrities and models." Lifes2Good said it disagreed with NAD's decision regarding the gender focus of its ads, but the Galway, Ireland-based firm agreed to comply with the recommendations
You may also be interested in...
Nutrafol Brushes Too Broadly With Hair Re-Growth Claims – ERSP
Nutraceutical Wellness will modify claims for Nutrafol Hair Re-Growth Supplement after ERSP finds two should be narrowed to clarify that ingredients and not the product were tested and that external factors impact hair health.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.